Loda M - Search Results

1

Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate.

Elfandy H, Armenia J, Pederzoli F, Pullman E, Pertega-Gomes N, Schultz N, Viswanathan K, Vosoughi A, Blattner M, Stopsack KH, Zadra G, Penney KL, Mosquera JM, Tyekucheva S, Mucci LA, Barbieri C, Loda M. Elfandy H, et al. Among authors: loda m. Mol Cancer Res. 2019 Feb;17(2):446-456. doi: 10.1158/1541-7786.MCR-18-0440. Epub 2018 Oct 17. Mol Cancer Res. 2019. PMID: 30333152 Free PMC article.

2

Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines.

Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, Jessup JM, Kolodner R. Kane MF, et al. Among authors: loda m. Cancer Res. 1997 Mar 1;57(5):808-11. Cancer Res. 1997. PMID: 9041175

3

Identification of genes expressed differentially by LNCaP or PC-3 prostate cancer cell lines.

Yang M, Loda M, Sytkowski AJ. Yang M, et al. Among authors: loda m. Cancer Res. 1998 Aug 15;58(16):3732-5. Cancer Res. 1998. PMID: 9721886

4

Gene expression correlates of clinical prostate cancer behavior.

Singh D, Febbo PG, Ross K, Jackson DG, Manola J, Ladd C, Tamayo P, Renshaw AA, D'Amico AV, Richie JP, Lander ES, Loda M, Kantoff PW, Golub TR, Sellers WR. Singh D, et al. Among authors: loda m. Cancer Cell. 2002 Mar;1(2):203-9. doi: 10.1016/s1535-6108(02)00030-2. Cancer Cell. 2002. PMID: 12086878 Free article.

5

Male patients with diagnoses of both breast cancer and prostate cancer.

Leibowitz SB, Garber JE, Fox EA, Loda M, Kaufman DS, Kantoff PW, Oh WK. Leibowitz SB, et al. Among authors: loda m. Breast J. 2003 May-Jun;9(3):208-12. doi: 10.1046/j.1524-4741.2003.09312.x. Breast J. 2003. PMID: 12752629

6

Fatty acid synthase expression defines distinct molecular signatures in prostate cancer.

Rossi S, Graner E, Febbo P, Weinstein L, Bhattacharya N, Onody T, Bubley G, Balk S, Loda M. Rossi S, et al. Among authors: loda m. Mol Cancer Res. 2003 Aug;1(10):707-15. Mol Cancer Res. 2003. PMID: 12939396

7

Heregulin targets gamma-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 oncoprotein.

Li Y, Yu WH, Ren J, Chen W, Huang L, Kharbanda S, Loda M, Kufe D. Li Y, et al. Among authors: loda m. Mol Cancer Res. 2003 Aug;1(10):765-75. Mol Cancer Res. 2003. PMID: 12939402

8

Genome-wide loss of heterozygosity analysis from laser capture microdissected prostate cancer using single nucleotide polymorphic allele (SNP) arrays and a novel bioinformatics platform dChipSNP.

Lieberfarb ME, Lin M, Lechpammer M, Li C, Tanenbaum DM, Febbo PG, Wright RL, Shim J, Kantoff PW, Loda M, Meyerson M, Sellers WR. Lieberfarb ME, et al. Among authors: loda m. Cancer Res. 2003 Aug 15;63(16):4781-5. Cancer Res. 2003. PMID: 12941794

9

Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor types.

Krop I, Player A, Tablante A, Taylor-Parker M, Lahti-Domenici J, Fukuoka J, Batra SK, Papadopoulos N, Richards WG, Sugarbaker DJ, Wright RL, Shim J, Stamey TA, Sellers WR, Loda M, Meyerson M, Hruban R, Jen J, Polyak K. Krop I, et al. Among authors: loda m. Mol Cancer Res. 2004 Sep;2(9):489-94. Mol Cancer Res. 2004. PMID: 15383627

10

Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells.

Berger R, Febbo PG, Majumder PK, Zhao JJ, Mukherjee S, Signoretti S, Campbell KT, Sellers WR, Roberts TM, Loda M, Golub TR, Hahn WC. Berger R, et al. Among authors: loda m. Cancer Res. 2004 Dec 15;64(24):8867-75. doi: 10.1158/0008-5472.CAN-04-2938. Cancer Res. 2004. PMID: 15604246

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

506 results

Search Page

Filters